| Jonathan Paul Kaufmann, DOCTOR OF PHARMACY | |
|
Walgreens Pharmacy, 533 South Lincoln Avenue, York, NE 68467 | |
| (402) 362-1280 | |
| Not Available |
| Full Name | Jonathan Paul Kaufmann |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | Walgreens Pharmacy, York, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124519566 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 11851 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan Paul Kaufmann, DOCTOR OF PHARMACY 533 S Lincoln Ave, York, NE 68467-4211 Ph: (308) 737-0164 | Jonathan Paul Kaufmann, DOCTOR OF PHARMACY Walgreens Pharmacy, 533 South Lincoln Avenue, York, NE 68467 Ph: (402) 362-1280 |
News Archive
Continucare Corporation announced today that its Board of Directors has approved the listing of the Company's common stock on the New York Stock Exchange (NYSE). Subject to the Company's continued compliance with the NYSE's initial listing standards, the Company expects to begin trading on the NYSE on or about November 1, 2010 under its current stock symbol "CNU."
Zafgen, a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced positive topline results from its Phase 1b study of ZGN-433, a methionine aminopeptidase 2 inhibitor, for the treatment of severe obesity.
A synthetic peptide appears to directly disrupt the destructive inflammation that occurs in nephritis, enabling the kidneys to better recover and maintain their important functions, investigators report.
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat specialty, critical and orphan central nervous system (CNS) disorders, today announced the successful completion of a $38 million Series C financing. OrbiMed Advisors, LLC, EcoR1 Capital Management, Foresite Capital Management and two undisclosed blue chip public investment funds joined existing investors Third Rock Ventures and ARCH Venture Partners.
Significant progress has been made in several low- and middle-income countries in increasing access to HIV/AIDS services, according to a new report released today. The report Towards universal access by WHO, the United Nations Children's Fund and the Joint United Nations Programme on HIV/AIDS is the fourth annual report for tracking progress made in achieving the 2010 target of providing universal access to HIV prevention, treatment and care.
› Verified 5 days ago
Mr. Charles Leon Moore, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2029 N Lincoln Ave, York, NE 68467 Phone: 402-362-4429 Fax: 402-362-4980 | |
Dr. Connie Bolte, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2029 N Lincoln Ave, York, NE 68467 Phone: 402-362-4429 | |
Ashley Ranae Hanson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 E David Dr, York, NE 68467 Phone: 402-362-2092 Fax: 402-362-2962 | |
Jacqueline Michele Wilkinson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 E David Dr, York, NE 68467 Phone: 402-362-2092 | |
David Dyer, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 533 S Lincoln Ave, York, NE 68467 Phone: 402-362-1280 Fax: 402-362-1355 | |
Dr. Ivy G Hanson, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 E David Dr, York, NE 68467 Phone: 402-362-2092 Fax: 402-362-2962 |